Platelet spleen tyrosine kinase is a key regulator of anti-PF4 antibody–induced immunothrombosis
Abstract: Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare but serious prothrombotic adverse event after vaccination with adenovector-based COVID-19 vaccines. Laboratory findings indicate that anti–platelet factor 4 (PF4) immunoglobulin G antibodies are the causing factor for the...
Saved in:
| Main Authors: | Jan Zlamal, Vera M. Ripoll, Christine S.M. Lee, Filip Toma, Karina Althaus, Flavianna Rigoni, Andreas Witzemann, Shane Whittaker, David Capraro, Günalp Uzun, Tamam Bakchoul, Vivien M. Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Blood Advances |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2473952924007377 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipid signatures of immunothrombosis: insights from VITT
by: Tamam Bakchoul, et al.
Published: (2025-02-01) -
<i>Staphylococcus aureus</i> Endocarditis Immunothrombosis
by: Francesco Nappi
Published: (2025-05-01) -
Platelet potential to switch to procoagulant phenotype compensates bleeding tendency in patients with hemophilia A
by: Karina Althaus, et al.
Published: (2025-03-01) -
Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases
by: Yaqi Zhou, et al.
Published: (2023-07-01) -
Spleen tyrosine kinase inhibitors disrupt human neutrophil swarming and antifungal functions
by: Alex Hopke, et al.
Published: (2025-01-01)